Back to search

Article

The impact of microsatellite instability in patients with locally advanced resectable gastric cancer undergoing perioperative therapy

2023-06-12

Abstract excerpt

<title>Abstract</title> <p>Background According to TCGA (The Cancer Genome Atlas) and ACRG (Asian Cancer Research Group) classifications, tumors with high microsatellite instability (MSI-H) are classified as a specific group. Currently, perioperative chemotherapy is a standard of care in patients with locally advanced resectable gastric cancer (LARGC) in Western countries. Immune checkpoint inhibitors (ICIs) hav...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
00b3e46e-afa5-518c-87e8-8e140889dbf5
DOI
10.21203/rs.3.rs-3037298/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The impact of microsatellite instability in patients with locally advanced resectable gastric cancer undergoing perioperative therapyDOI 10.21203/rs.3.rs-3037298/v1
Analysis of perioperative chemotherapy-mediated genomic changes in gastric cancerSemantic proximity
Analysis of perioperative chemotherapy-mediated genomic changes in gastric cancer.Semantic proximity
Efficacy and safety of neoadjuvant immunotherapy in patients with microsatellite instability-high gastrointestinal malignancies: A case series.Semantic proximity
[Localized MSI/dMMR gastric cancer patients, perioperative immunotherapy instead of chemotherapy: The GERCOR NEONIPIGA phase II study is opened to recruitment].Semantic proximity
Molecular features and prognostic factors of locally advanced microsatellite instability-high gastric cancer.Semantic proximity
Efficacy and safety of neoadjuvant toripalimab plus chemotherapy in localized deficient mismatch repair/microsatellite instability-high gastric or esophagogastric junction adenocarcinoma (NICE): a multicentre, single-arm, exploratory phase 2 studySemantic proximity
Characteristics of Subtypes Within Microsatellite Instability-high Gastric Cancer Based on a Gene Signature Related to Immune Microenvironment ComponentsSemantic proximity
Low incidence of microsatellite instability in gastric cancers and its association with the clinicopathological characteristics: a comparative studySemantic proximity
A randomized, open, multicenter Phase II study to explore the sequential use of chemotherapy and immunotherapy in postoperative adjuvant therapy for gastric or esophagogastric junction adenocarcinoma or colorectal adenocarcinoma with radical resection of POLE/POLD1 gene mutation or dMMR/MSI-HSemantic proximity
Effects of perioperative treatment of resectable adenocarcinoma of esophagogastric junction by immunotherapy (Adebrelimab) combined with chemotherapy (XELOX): protocol for a single-center, open-labeled study (AEGIS trial, neoadjuvant immunochemotherapy)Semantic proximity
Evaluation of ctDNA in Predicting Response to Neoadjuvant Therapy and Analysis of Residual Disease in Local Advanced Gastric Cancer: Protocol of A Single-Arm Multicenter Prospective Observational StudySemantic proximity
Microsatellite instability in gastric cancer: molecular bases, clinical perspectives, and new treatment approachesSemantic proximity
Select a neighboring publication to make it the new centre.